DNLI
Denali Therapeutics Inc
20.50$
+3.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -402.5% | – | -150.8% | – | – | – | – | |
| – | +1,114.0% | +109.8% | +140.6% | +7.8% | +6.8% | +0.7% | +20.8% | +61.1% | -46.2% | +64.7% | |
| – | +516.1% | +49.4% | +326.2% | +104.2% | +31.2% | +69.3% | +17.1% | +8.3% | -4.8% | -3.2% | |
| – | +618.1% | -39.5% | +263.3% | +102.8% | +32.5% | +80.6% | +4.3% | – | – | – | |
| – | +906.1% | -22.9% | +1,802.9% | -95.4% | +9,770.0% | -107.1% | – | – | – | -99.1% | |
| – | +100.3% | -53.1% | +18.0% | +428.1% | -82.7% | +174.6% | +109.8% | -27.4% | +23.0% | -40.3% | |
| – | +7,052.3% | -81.2% | +598.2% | – | -521.9% | -96.5% | +553.8% | – | -135.6% | – | |
| – | +585.2% | -1.4% | -99.1% | +136.9% | +3,366.9% | -91.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -74.7% | |
| – | +515.0% | -1.4% | -67.3% | -93.6% | +10,154.4% | -97.0% | +1,505.7% | -94.3% | +2,617.8% | -60.9% | |
| – | -70.4% | +1,859.0% | -178.6% | – | +18,287.6% | -150.0% | – | – | – | -33.3% | |
| – | – | – | – | -462.8% | – | -153.2% | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.